Pharmaceutical firm names new CFO

Julphar Gulf Pharmaceutical Industries has appointed Mr Laurent de Chazeaux as its acting chief financial officer. He replaced Jerome Carle, who has been appointed the company’s general manager. The appointment is with immediate effect. The company’s Chairman, Sheikh Faisal Bin Saqr Al Qasimi, in a statement, explained that Chazeaux was an established financial executive with […]

Julphar Gulf Pharmaceutical Industries has appointed Mr Laurent de Chazeaux as its acting chief financial officer.

He replaced Jerome Carle, who has been appointed the company’s general manager. The appointment is with immediate effect.

The company’s Chairman, Sheikh Faisal Bin Saqr Al Qasimi, in a statement, explained that Chazeaux was an established financial executive with extensive background overseeing finance organisations.

As Acting CFO, Chazeaux would be leading the company’s finance department and keeping accurate financial records.

He would report to the company’s General Manager, Jerome Carle.

Over the last 20 years, Chazeaux has worked in a number of senior finance roles in the pharmaceutical industry and in investment banking.

He spent several years working for Cowen, where he was in charge of analysing performances of midsize European pharmaceutical companies, and before joining Julphar as associate director, finance in June 2017, he worked at Sanofi and as finance director at AstraZeneca.